COVID-19 has brought attention back to deadly viruses. Meet hard-working scientists in Singapore and elsewhere racing to identify emerging pathogens, battle existing viruses and co-operate to find urgently-needed treatments and vaccines.
Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are prioritized for R&D in public health emergency contexts.
